Books: The Immortal Life of Henrietta Lacks

For indispensable reporting on the coronavirus crisis and more, subscribe to Mother Jones' newsletters.


When Henrietta Lacks—a poor, African American tobacco farmer from Virginia—checked into Johns Hopkins Hospital with cervical cancer in 1951, she had no idea that tissue removed from her body without her consent would become one of the most important resources in medical history. She died soon afterward, but her cells, dubbed HeLa, astonished scientists with their still-mysterious “immortality”—they were the first ones to survive indefinitely in the lab, and reproduced at an unprecedented rate. HeLa provided the raw material necessary to develop the polio vaccine and many other medical breakthroughs. In this gripping, vibrant book, Rebecca Skloot looks beyond the scientific marvels to explore the ethical issues behind a discovery that may have saved your life.

Skloot pinpoints HeLa as the origin of many ethical debates that still define modern science, tissue research, and the ownership of the body. Since learning about HeLa in 1973, Lacks’ husband and children have felt betrayed by what they see as a medical establishment that secretly experimented on and exploited black patients. Some of Lacks’ relatives wonder why they shouldn’t get a cut from what is still one of the world’s most popular—and profitable—cell lines: All the HeLa cells ever made would weigh 22 tons; a single vial can sell for nearly $10,000.

Skloot spends nearly 10 years earning the trust of Lacks’ daughter Deborah, who’s also obsessed with learning more about her mother. She still runs up against the Lackses’ understandable suspicion, such as when Deborah slams her up against a wall and asks if she’s really working for Johns Hopkins—but Skloot persists, intent on paying homage to the flesh-and-blood woman behind HeLa.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.